COMMUNIQUÉS West-GlobeNewswire

VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents
28/05/2019
-Post-marketing study designed to evaluate Qsymia as an approach to weight management in a growing patient population with significant unmet medical need- CAMPBELL, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. ( [...]
Translate Bio to Present at the Jefferies 2019 Healthcare Conference
28/05/2019
LEXINGTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
28/05/2019
NEWTOWN, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial [...]
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in [...]
ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer’s Disease with Selectivity for the Neurotoxic Form of Tau
28/05/2019
Pipeline offers critical “one-two punch” in potential treatment arsenal for Alzheimer’s disease TORONTO and CAMBRIDGE, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a [...]
Akcea Therapeutics to Present at Upcoming Investor Conferences
28/05/2019
BOSTON, May 28, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare [...]
Kezar Life Sciences Announces Acceptance of Abstract for Presentation of First in Patient Study with KZR-616 at EULAR 2019 Annual Meeting
28/05/2019
Abstract highlights preliminary results from the first two cohorts of the Phase 1b portion of the MISSION Trial in patients with systemic lupus erythematosus (SLE) Detailed poster with additional results will be [...]
RedHill Biopharma Appoints Dr. June Almenoff as Chief Scientific Officer
28/05/2019
TEL-AVIV, Israel and RALEIGH, N.C., May 28, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
AnaptysBio to Present at the Jefferies 2019 Healthcare Conference
28/05/2019
SAN DIEGO, May 28, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
28/05/2019
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen- [...]
BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
28/05/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, May 28, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
HEXO Corp formalizes US presence by naming Michael Monahan as Chief Financial Officer and establishing HEXO USA Inc. in Delaware
28/05/2019
GATINEAU, Quebec, May 28, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is formalizing its US presence with the appointment of Michael Monahan as Chief Financial Officer (CFO) [...]
HEXO Corp officialise sa présence aux États-Unis : nomination de Michael Monahan à titre de directeur des finances et création d’HEXO USA Inc. dans le Delaware
28/05/2019
GATINEAU, Québec, 28 mai 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO; NYSE-A: HEXO) officialise sa présence aux États-Unis avec la nomination de Michael Monahan au poste de directeur des [...]
Quotient Limited Recaps Recent Milestone Achievement and Updates on the Initial Serological Disease Screening CE Mark Submission, planned 2019 US Field Trials and Reports Record Financial Results
28/05/2019
CE mark received on the initial Immunohematology microarray in April 2019 2018 manufacturing site certification and MosaiQ™ device CE mark combine with the recent approval to permit commercialization Successful European [...]
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference
28/05/2019
Company taking active role with two podium presentations, panel participation and session chair CLEVELAND, May 28, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its participation in several [...]
Transactions in relation to share buyback program
28/05/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022
28/05/2019
Press Release 28 May 2019 Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022 Immunicum AB (publ) announced today the completion of the subscription of options in the long-term [...]
OSE Immunotherapeutics to Present at 5th Annual Immuno-Oncology: BD&L and Investment Forum
28/05/2019
Forum to be held in Chicago, IL, on May 31, 2019 NANTES, France, May 28, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that Alexis Peyroles, chief executive officer, [...]
Herantis Pharma Plc shares subscribed with option rights
28/05/2019
Herantis Pharma Plc shares subscribed with option rights Herantis Pharma Plc Company release 28 May 2019 at 9:00am 32,000 new shares of Herantis Pharma Plc have been subscribed with option rights of the option programs [...]

Pages